Jacob Waldrop
Fortune : 575 053 $ au 30/06/2026
Fortune : 575 053 $ au 30/06/2026
Jacob A. Waldrop is Chief Operating Officer at Sanara MedTech, Inc. since 2024.
Formerly, Mr. Waldrop was Chief Financial Officer at Trilliant Surgical LLC and Vice President-Finance & Integrations at Enovis Corp.
Mr. Waldrop completed undergraduate studies at Texas A&M University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANARA MEDTECH, INC. 0,27 % | 15/04/2026 | 24 377 ( 0,27 % ) | 575 053 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SANARA MEDTECH INC. | Directeur des opérations | 15/04/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Directeur Financier/CFO | - |
| ENOVIS CORPORATION | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Sanara MedTech, Inc.
Sanara MedTech, Inc. Medical SpecialtiesHealth Technology Provides medical products, advanced biotechnology solutions and applications | Health Technology |
Enovis Corp.
Enovis Corp. Medical SpecialtiesHealth Technology Develops, manufactures and supplies medical devices used for reconstructive surgery, rehabilitation, pain management and physical therapy | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national